InvestorsHub Logo
Followers 74
Posts 1863
Boards Moderated 0
Alias Born 04/30/2011

Re: None

Tuesday, 11/29/2016 7:30:47 PM

Tuesday, November 29, 2016 7:30:47 PM

Post# of 8426
I read it. Good post. Couple of things incorrect though. Riley didnt know Trimesta was going to fail. I don't think he liked having it as legacy trial when he took over the company, but he had the same info we all did and definite failure wasn't indicated. Also, it is likely that there were interested parties and discussions occurring. External partnership inquiries likely included waiting until the trial results with MRI translations were finished before serious offers made. Buying blind to that pending info would have been an act of naivete uncommon to biotech.
Also, the CDC does not have a role of pushing drugs to FDA for approval purposes. So, there is no scenario where CDC will assist in 004s approval other than its enhancement of 004 evidence pool thru knowlege gained with current grant.
Other than those small things, I think the post was well thought out and presents some possible scenarios.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOVX News